The global anti-infective vaccines market, which achieved a valuation of approximately USD 51.0 Billion in 2021, is poised for substantial growth, forecasting a robust Compound Annual Growth Rate (CAGR) of 12.3% through 2032. Analysts predict this trajectory will propel the market to an impressive USD 168.7 Billion by the end of the forecast period. The …